Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US7170811035
Ticker PFE
Company PFIZER
Currency $
Price
Aware Investor Index (AII) 5.2025
Recommendation BUY
P/E 21.71
ROE 16.29 %
Capitalization 252,315,700,000 $
Dividend Yield 3.07 %
P/S 4.80
AII Position 138
P/E Position 285
ROE Position 210
Capitalization Position 31
Dividend Yield Position 218
Sales 52,546,000,000 $
10-Year Average Earnings 11,619,600,000 $
Shares Outstanding 6,058,000,000
Equity 71,308,000,000 $
Dividend per Share 1.28 $
Industry Pharmaceutical
Country United States
PFIZER Investor Relations Web Site http://www.pfizer.com/investors/







Sales:

YEAR MONTH AMOUNT
2017 12 52,546,000,000.00 $
2016 12 52,824,000,000.00 $
2015 12 48,851,000,000.00 $
2014 12 49,605,000,000.00 $
2013 12 51,584,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2017 12 21,308,000,000.00 $
2016 12 7,215,000,000.00 $
2015 12 6,960,000,000.00 $
2014 12 9,135,000,000.00 $
2013 12 22,003,000,000.00 $
2012 12 14,570,000,000.00 $
2011 12 10,009,000,000.00 $
2010 12 8,257,000,000.00 $
2009 12 8,635,000,000.00 $
2008 12 8,104,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2017 12 71,308,000,000.00 $
2016 12 59,544,000,000.00 $
2015 12 64,998,000,000.00 $
2014 12 71,622,000,000.00 $
2013 12 76,620,000,000.00 $
2012 12 81,678,000,000.00 $
2011 12 82,621,000,000.00 $
2010 12 88,265,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 6,058,000,000
2016 12 6,159,000,000
2015 12 6,257,000,000
2014 12 6,424,000,000
2013 12 6,895,000,000
2012 12 7,508,000,000
2011 12 7,870,000,000
2010 12 8,074,000,000
2009 12 7,045,000,000

 












Bloomberg News for PFIZER:



Google News for PFIZER:

Motley Fool - 1 day ago
Where Will Pfizer Be in 5 Years?
Over the last five years Pfizer (NYSE:PFE) has delivered 67% price appreciation plus healthy dividends, compared with a 49% gain for the S&P ...
Mayfield Recorder - 7 hours ago
Pfizer (PFE) Stock Rating Reaffirmed by Barclays
Barclays reiterated their hold rating on shares of Pfizer (NYSE:PFE) in a research report released on Thursday, May 9th, AnalystRatings.com ...
Alpha finews (press release)
Better Buy: Eli Lilly vs. Pfizer
If you're looking to add a big pharma stock to your portfolio, Eli Lilly (NYSE:LLY) and Pfizer (NYSE:PFE) are naturally two top candidates.
Rockland Register
Pfizer $PFE Technical Update
The Pfizer (NYSE: PFE) update and the technical summary table below can help you manage risk and optimize returns. We have day, swing, ...
Tech Know Bits
Pfizer Acquires Therachon, Looks To Add To Rare Disease Pipeline
Pfizer (PFE) acquired a private biotech by the name of Therachon. The reason for doing so is to add several rare disease drugs into its pipeline.
Motley Fool - 12 hours ago
As Pfizer (PFE) Stock Price Declined, First Midwest Bank Trust ...
As Pfizer (PFE) Stock Price Declined, First Midwest Bank Trust Division Has Upped Its Holding; Caseys Gen Stores (CASY) Stock Value Rose ...
Stock Traders Daily - 10 hours ago
Pfizer (PFE) Holder Pettee Investors Trimmed Its Position by ...
Pettee Investors Inc decreased its stake in Pfizer (PFE) by 7.5% based on its latest 2018Q4 regulatory filing with the SEC. Pettee Investors Inc ...
Seeking Alpha - 4 days ago
Intersect Capital Increases Stake in Johnson & Johnson (JNJ); As ...
Intersect Capital Increases Stake in Johnson & Johnson (JNJ); As Pfizer (PFE) Valuation Declined, Shareholder American Investment Services ...
CryptoCoinsTribune - 7 hours ago
Placing the Spotlight on Pfizer Inc (PFE): Technical Stock Update
Pfizer Inc (PFE)'s MACD Histogram reading is currently above the zero line, indicating a positive chart trend for the shares. Shares recently ...
CryptoCoinsTribune - 7 hours ago
Pfizer Inc. (PFE) Is At $41.47 Formed Wedge; Harsco (HSC) Has 1.1 ...
Pfizer Inc. (PFE) formed wedge down with $39.40 target or 5.00% below today's $41.47 share price. Pfizer Inc. (PFE) has $230.23 billion ...


Back